QTTB Q32 Bio
Q32 Bio earnings company data as of 4:48 AM ET 10/23
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 12 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by QTTB's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $30M bought by 2 insiders
- $109K sold by 2 insiders outside a trading plan
- None no planned (10b5-1) sales
-
Diyong Xu DirectorBuy$15M 1,875,000 shares at $8.00 New stakeTraded May 28 Filed Jun 1
-
Jodie Pope Morrison CEOSale$78K 22,506 shares at $3.46 19% of stakeTraded Dec 2, 2025 Filed Dec 4, 2025
-
Lee Kalowski CFOSale$31K 9,072 shares at $3.46 19% of stakeTraded Dec 2, 2025 Filed Dec 4, 2025
Also filed in the last 12 months, not counted as buying or selling: 9 sales to cover taxes, 6 stock grants, and 1 option exercise.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 424B3 | Filing Doc | ||
| SCHEDULE 13D/A | — | Filing Doc | |
| 424B5 | Filing Doc | ||
| 8-K | 1.01,9.01 | Filing Doc | |
| 8-K | 7.01,8.01,9.01 | Filing Doc | |
| 8-K | 8.01,9.01 | Filing Doc | |
| 424B5 | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.